Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
ANI Pharmaceuticals Inc's ANIP third-quarter revenues were $131.8 million, up 57.3% Y/Y, beating the consensus of $111.92 million. Net revenues for generic pharmaceutical products were $63.7 million, up 29.7%, driven by increased volume from the annualization of 2022 launches and a favorable…
#establishedbrands #cortrophingel #eps #anipharmaceuticals